Home/Filings/4/0000905148-24-001485
4//SEC Filing

Devroe Eric 4

Accession 0000905148-24-001485

CIK 0001781174other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 6:56 PM ET

Size

4.4 KB

Accession

0000905148-24-001485

Insider Transaction Report

Form 4
Period: 2024-05-14
Devroe Eric
Chief Operating Officer
Transactions
  • Tax Payment

    Common Stock

    2024-05-14$8.36/sh613$5,12559,097 total
Footnotes (1)
  • [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

1 file

Issuer

Acrivon Therapeutics, Inc.

CIK 0001781174

Entity typeother

Related Parties

1
  • filerCIK 0001950573

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 6:56 PM ET
Size
4.4 KB